HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-OCT-16 5TQ3 TITLE DESIGN AND SYNTHESIS OF A PAN-JAK KINASE INHIBITOR CLINICAL CANDIDATE TITLE 2 (PF-06263276) SUITABLE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF TITLE 3 THE LUNGS AND SKIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 837-1132; COMPND 5 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS KINASE, INFLAMMATION, JAK INHIBITOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.CHRENCIK,P.JONES REVDAT 7 06-NOV-24 5TQ3 1 REMARK REVDAT 6 15-NOV-23 5TQ3 1 REMARK REVDAT 5 04-OCT-23 5TQ3 1 REMARK REVDAT 4 09-AUG-17 5TQ3 1 REMARK REVDAT 3 08-FEB-17 5TQ3 1 JRNL REVDAT 2 18-JAN-17 5TQ3 1 JRNL REVDAT 1 11-JAN-17 5TQ3 0 JRNL AUTH P.JONES,R.I.STORER,Y.A.SABNIS,F.M.WAKENHUT,G.A.WHITLOCK, JRNL AUTH 2 K.S.ENGLAND,T.MUKAIYAMA,C.M.DEHNHARDT,J.W.COE,S.W.KORTUM, JRNL AUTH 3 J.E.CHRENCIK,D.G.BROWN,R.M.JONES,J.R.MURPHY,T.YEOH,P.MORGAN, JRNL AUTH 4 I.KILTY JRNL TITL DESIGN AND SYNTHESIS OF A PAN-JANUS KINASE INHIBITOR JRNL TITL 2 CLINICAL CANDIDATE (PF-06263276) SUITABLE FOR INHALED AND JRNL TITL 3 TOPICAL DELIVERY FOR THE TREATMENT OF INFLAMMATORY DISEASES JRNL TITL 4 OF THE LUNGS AND SKIN. JRNL REF J. MED. CHEM. V. 60 767 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 27983835 JRNL DOI 10.1021/ACS.JMEDCHEM.6B01634 REMARK 2 REMARK 2 RESOLUTION. 2.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.54 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 15717 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 858 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.69 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 REFLECTION IN BIN (WORKING SET) : 800 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.13 REMARK 3 BIN R VALUE (WORKING SET) : 0.2830 REMARK 3 BIN FREE R VALUE SET COUNT : 45 REMARK 3 BIN FREE R VALUE : 0.3420 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4599 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 53 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.66000 REMARK 3 B22 (A**2) : 0.71000 REMARK 3 B33 (A**2) : -0.16000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.22000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.419 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.307 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.825 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.912 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.857 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4769 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4445 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6451 ; 1.571 ; 1.972 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10223 ; 0.820 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 568 ;10.159 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 218 ;37.548 ;24.220 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 838 ;18.423 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;18.005 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 685 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5589 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1087 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2284 ; 2.309 ; 3.678 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2283 ; 2.307 ; 3.676 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2848 ; 3.766 ; 5.507 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2849 ; 3.766 ; 5.509 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2485 ; 2.372 ; 3.825 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2423 ; 2.394 ; 3.860 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3513 ; 3.862 ; 5.694 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 19391 ; 7.228 ;33.921 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 19277 ; 7.246 ;33.978 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5TQ3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1000224630. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16600 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.690 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3TJC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES, PH 7.5, 0.1 M SODIUM REMARK 280 ACETATE, 30% PEG3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 91.36300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 829 REMARK 465 GLY A 830 REMARK 465 HIS A 831 REMARK 465 HIS A 832 REMARK 465 HIS A 833 REMARK 465 HIS A 834 REMARK 465 HIS A 835 REMARK 465 HIS A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 THR A 842 REMARK 465 LYS A 1011 REMARK 465 GLU A 1012 REMARK 465 ASP A 1068 REMARK 465 LYS A 1069 REMARK 465 GLN A 1070 REMARK 465 GLY A 1071 REMARK 465 MET B 829 REMARK 465 GLY B 830 REMARK 465 HIS B 831 REMARK 465 HIS B 832 REMARK 465 HIS B 833 REMARK 465 HIS B 834 REMARK 465 HIS B 835 REMARK 465 HIS B 836 REMARK 465 GLU B 837 REMARK 465 ASP B 838 REMARK 465 ARG B 839 REMARK 465 ASP B 840 REMARK 465 PRO B 841 REMARK 465 THR B 842 REMARK 465 ASP B 1068 REMARK 465 LYS B 1069 REMARK 465 GLN B 1070 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 845 OE1 OE2 REMARK 470 ASP A 873 CG OD1 OD2 REMARK 470 ASN A 874 CG OD1 ND2 REMARK 470 LYS A 883 CD CE NZ REMARK 470 GLU A 890 CD OE1 OE2 REMARK 470 ARG A 893 CD NE CZ NH1 NH2 REMARK 470 ARG A 923 CZ NH1 NH2 REMARK 470 ARG A 938 CZ NH1 NH2 REMARK 470 LYS A 943 NZ REMARK 470 GLU A 946 CG CD OE1 OE2 REMARK 470 ARG A 947 CD NE CZ NH1 NH2 REMARK 470 ILE A 951 CD1 REMARK 470 LYS A 962 CE NZ REMARK 470 GLU A1028 OE1 OE2 REMARK 470 LYS A1053 CG CD CE NZ REMARK 470 ASN A1067 CG OD1 ND2 REMARK 470 GLN A1072 CG CD OE1 NE2 REMARK 470 SER A1073 OG REMARK 470 GLU A1080 CD OE1 OE2 REMARK 470 ARG A1117 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 847 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 857 CE NZ REMARK 470 ASN B 859 CG OD1 ND2 REMARK 470 ASP B 873 CG OD1 OD2 REMARK 470 ASN B 874 CG OD1 ND2 REMARK 470 ARG B 893 CZ NH1 NH2 REMARK 470 ARG B 923 NE CZ NH1 NH2 REMARK 470 ARG B 947 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 951 CD1 REMARK 470 LYS B 962 CE NZ REMARK 470 GLU B 987 CG CD OE1 OE2 REMARK 470 LYS B1011 CD CE NZ REMARK 470 LYS B1053 CG CD CE NZ REMARK 470 ASN B1067 CG OD1 ND2 REMARK 470 GLN B1072 CG CD OE1 NE2 REMARK 470 GLU B1080 CD OE1 OE2 REMARK 470 ARG B1117 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A1013 CB - CA - C ANGL. DEV. = -27.0 DEGREES REMARK 500 PRO A1013 N - CA - C ANGL. DEV. = 25.2 DEGREES REMARK 500 GLY A1014 N - CA - C ANGL. DEV. = -16.6 DEGREES REMARK 500 ARG B 922 N - CA - CB ANGL. DEV. = -15.6 DEGREES REMARK 500 ILE B1074 N - CA - C ANGL. DEV. = -20.1 DEGREES REMARK 500 ALA B1131 CB - CA - C ANGL. DEV. = -11.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 872 8.19 57.77 REMARK 500 GLN A 885 -71.67 -72.64 REMARK 500 SER A 887 44.29 -85.21 REMARK 500 ASP A 976 38.07 -144.18 REMARK 500 SER A1073 -161.14 -103.46 REMARK 500 TRP A1106 37.40 -95.20 REMARK 500 GLN B 872 6.14 57.58 REMARK 500 GLN B 885 -72.31 -71.35 REMARK 500 SER B 887 43.21 -85.57 REMARK 500 ASP B 976 37.01 -143.82 REMARK 500 LYS B1011 35.75 97.20 REMARK 500 GLU B1012 -61.64 176.94 REMARK 500 PRO B1013 -169.76 -37.77 REMARK 500 SER B1073 -169.36 -69.37 REMARK 500 TRP B1106 36.68 -92.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 873 ASN A 874 -59.77 REMARK 500 GLY A 921 ARG A 922 141.95 REMARK 500 ARG A 922 ARG A 923 -125.77 REMARK 500 ILE A 992 GLY A 993 122.37 REMARK 500 GLY A 1014 GLU A 1015 144.22 REMARK 500 GLN A 1072 SER A 1073 -37.73 REMARK 500 ASP B 873 ASN B 874 -99.51 REMARK 500 GLY B 921 ARG B 922 108.10 REMARK 500 ILE B 992 GLY B 993 86.74 REMARK 500 GLY B 1066 ASN B 1067 -34.35 REMARK 500 SER B 1073 ILE B 1074 -133.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 VAL B1010 -12.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7GZ A 4000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7GZ B 4001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TQ8 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ7 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ6 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ5 RELATED DB: PDB REMARK 900 RELATED ID: 5TQ4 RELATED DB: PDB DBREF 5TQ3 A 837 1132 UNP O60674 JAK2_HUMAN 837 1132 DBREF 5TQ3 B 837 1132 UNP O60674 JAK2_HUMAN 837 1132 SEQADV 5TQ3 MET A 829 UNP O60674 INITIATING METHIONINE SEQADV 5TQ3 GLY A 830 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS A 831 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS A 832 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS A 833 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS A 834 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS A 835 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS A 836 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 SER A 1073 UNP O60674 MET 1073 ENGINEERED MUTATION SEQADV 5TQ3 THR A 1076 UNP O60674 PHE 1076 ENGINEERED MUTATION SEQADV 5TQ3 VAL A 1126 UNP O60674 ILE 1126 ENGINEERED MUTATION SEQADV 5TQ3 MET B 829 UNP O60674 INITIATING METHIONINE SEQADV 5TQ3 GLY B 830 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS B 831 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS B 832 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS B 833 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS B 834 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS B 835 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 HIS B 836 UNP O60674 EXPRESSION TAG SEQADV 5TQ3 SER B 1073 UNP O60674 MET 1073 ENGINEERED MUTATION SEQADV 5TQ3 THR B 1076 UNP O60674 PHE 1076 ENGINEERED MUTATION SEQADV 5TQ3 VAL B 1126 UNP O60674 ILE 1126 ENGINEERED MUTATION SEQRES 1 A 304 MET GLY HIS HIS HIS HIS HIS HIS GLU ASP ARG ASP PRO SEQRES 2 A 304 THR GLN PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN SEQRES 3 A 304 LEU GLY LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG SEQRES 4 A 304 TYR ASP PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA SEQRES 5 A 304 VAL LYS LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG SEQRES 6 A 304 ASP PHE GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN SEQRES 7 A 304 HIS ASP ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER SEQRES 8 A 304 ALA GLY ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU SEQRES 9 A 304 PRO TYR GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS SEQRES 10 A 304 GLU ARG ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER SEQRES 11 A 304 GLN ILE CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG SEQRES 12 A 304 TYR ILE HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL SEQRES 13 A 304 GLU ASN GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU SEQRES 14 A 304 THR LYS VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS VAL SEQRES 15 A 304 LYS GLU PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO SEQRES 16 A 304 GLU SER LEU THR GLU SER LYS PHE SER VAL ALA SER ASP SEQRES 17 A 304 VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR SEQRES 18 A 304 TYR ILE GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET SEQRES 19 A 304 ARG MET ILE GLY ASN ASP LYS GLN GLY GLN SER ILE VAL SEQRES 20 A 304 THR HIS LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU SEQRES 21 A 304 PRO ARG PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE SEQRES 22 A 304 MET THR GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SEQRES 23 A 304 SER PHE ARG ASP LEU ALA LEU ARG VAL ASP GLN VAL ARG SEQRES 24 A 304 ASP ASN MET ALA GLY SEQRES 1 B 304 MET GLY HIS HIS HIS HIS HIS HIS GLU ASP ARG ASP PRO SEQRES 2 B 304 THR GLN PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN SEQRES 3 B 304 LEU GLY LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG SEQRES 4 B 304 TYR ASP PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA SEQRES 5 B 304 VAL LYS LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG SEQRES 6 B 304 ASP PHE GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN SEQRES 7 B 304 HIS ASP ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER SEQRES 8 B 304 ALA GLY ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU SEQRES 9 B 304 PRO TYR GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS SEQRES 10 B 304 GLU ARG ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER SEQRES 11 B 304 GLN ILE CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG SEQRES 12 B 304 TYR ILE HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL SEQRES 13 B 304 GLU ASN GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU SEQRES 14 B 304 THR LYS VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS VAL SEQRES 15 B 304 LYS GLU PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO SEQRES 16 B 304 GLU SER LEU THR GLU SER LYS PHE SER VAL ALA SER ASP SEQRES 17 B 304 VAL TRP SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR SEQRES 18 B 304 TYR ILE GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET SEQRES 19 B 304 ARG MET ILE GLY ASN ASP LYS GLN GLY GLN SER ILE VAL SEQRES 20 B 304 THR HIS LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU SEQRES 21 B 304 PRO ARG PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE SEQRES 22 B 304 MET THR GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SEQRES 23 B 304 SER PHE ARG ASP LEU ALA LEU ARG VAL ASP GLN VAL ARG SEQRES 24 B 304 ASP ASN MET ALA GLY MODRES 5TQ3 PTR A 1007 TYR MODIFIED RESIDUE MODRES 5TQ3 PTR A 1008 TYR MODIFIED RESIDUE MODRES 5TQ3 PTR B 1007 TYR MODIFIED RESIDUE MODRES 5TQ3 PTR B 1008 TYR MODIFIED RESIDUE HET PTR A1007 16 HET PTR A1008 16 HET PTR B1007 16 HET PTR B1008 16 HET 7GZ A4000 27 HET 7GZ B4001 27 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 7GZ 4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-3- HETNAM 2 7GZ ETHYLPHENOL HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 7GZ 2(C22 H18 N4 O) FORMUL 5 HOH *53(H2 O) HELIX 1 AA1 GLU A 845 ARG A 847 5 3 HELIX 2 AA2 THR A 888 SER A 904 1 17 HELIX 3 AA3 SER A 936 LYS A 945 1 10 HELIX 4 AA4 GLU A 946 ILE A 948 5 3 HELIX 5 AA5 ASP A 949 LYS A 970 1 22 HELIX 6 AA6 ALA A 978 ARG A 980 5 3 HELIX 7 AA7 PRO A 1017 TYR A 1021 5 5 HELIX 8 AA8 ALA A 1022 SER A 1029 1 8 HELIX 9 AA9 SER A 1032 THR A 1049 1 18 HELIX 10 AB1 GLU A 1052 LYS A 1055 5 4 HELIX 11 AB2 SER A 1056 GLY A 1066 1 11 HELIX 12 AB3 SER A 1073 ASN A 1084 1 12 HELIX 13 AB4 PRO A 1095 TRP A 1106 1 12 HELIX 14 AB5 ASN A 1109 ARG A 1113 5 5 HELIX 15 AB6 SER A 1115 GLY A 1132 1 18 HELIX 16 AB7 GLU B 845 ARG B 847 5 3 HELIX 17 AB8 THR B 888 SER B 904 1 17 HELIX 18 AB9 SER B 936 LYS B 945 1 10 HELIX 19 AC1 GLU B 946 ILE B 948 5 3 HELIX 20 AC2 ASP B 949 LYS B 970 1 22 HELIX 21 AC3 ALA B 978 ARG B 980 5 3 HELIX 22 AC4 PRO B 1017 TYR B 1021 5 5 HELIX 23 AC5 ALA B 1022 SER B 1029 1 8 HELIX 24 AC6 SER B 1032 THR B 1049 1 18 HELIX 25 AC7 GLU B 1052 LYS B 1055 5 4 HELIX 26 AC8 SER B 1056 GLY B 1066 1 11 HELIX 27 AC9 SER B 1073 ASN B 1084 1 12 HELIX 28 AD1 PRO B 1095 TRP B 1106 1 12 HELIX 29 AD2 ASN B 1109 ARG B 1113 5 5 HELIX 30 AD3 SER B 1115 GLY B 1132 1 18 SHEET 1 AA1 5 LEU A 849 LYS A 857 0 SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 AA1 5 GLU A 877 LEU A 884 -1 O VAL A 879 N CYS A 866 SHEET 4 AA1 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 AA1 5 TYR A 913 CYS A 917 -1 N LYS A 914 O ILE A 928 SHEET 1 AA2 2 TYR A 972 ILE A 973 0 SHEET 2 AA2 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AA3 2 ILE A 982 ASN A 986 0 SHEET 2 AA3 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 AA4 2 PTR A1008 LYS A1009 0 SHEET 2 AA4 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 SHEET 1 AA5 5 LEU B 849 LYS B 857 0 SHEET 2 AA5 5 GLY B 861 TYR B 868 -1 O MET B 865 N GLN B 853 SHEET 3 AA5 5 GLU B 877 LEU B 884 -1 O VAL B 879 N CYS B 866 SHEET 4 AA5 5 LYS B 926 GLU B 930 -1 O MET B 929 N ALA B 880 SHEET 5 AA5 5 TYR B 913 CYS B 917 -1 N LYS B 914 O ILE B 928 SHEET 1 AA6 2 TYR B 972 ILE B 973 0 SHEET 2 AA6 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 AA7 2 ILE B 982 ASN B 986 0 SHEET 2 AA7 2 ARG B 989 ILE B 992 -1 O LYS B 991 N LEU B 983 SHEET 1 AA8 2 PTR B1008 LYS B1009 0 SHEET 2 AA8 2 LYS B1030 PHE B1031 -1 O PHE B1031 N PTR B1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.34 LINK C PTR A1007 N PTR A1008 1555 1555 1.34 LINK C PTR A1008 N LYS A1009 1555 1555 1.33 LINK C GLU B1006 N PTR B1007 1555 1555 1.34 LINK C PTR B1007 N PTR B1008 1555 1555 1.33 LINK C PTR B1008 N LYS B1009 1555 1555 1.31 CISPEP 1 PRO A 1013 GLY A 1014 0 -21.94 CISPEP 2 GLY A 1066 ASN A 1067 0 -8.45 CISPEP 3 VAL B 1010 LYS B 1011 0 11.48 CISPEP 4 LYS B 1011 GLU B 1012 0 4.39 SITE 1 AC1 14 LEU A 855 ALA A 880 GLU A 898 LEU A 902 SITE 2 AC1 14 LEU A 927 MET A 929 GLU A 930 TYR A 931 SITE 3 AC1 14 LEU A 932 PRO A 933 GLY A 935 LEU A 983 SITE 4 AC1 14 GLY A 993 PHE A 995 SITE 1 AC2 14 LEU B 855 ALA B 880 GLU B 898 LEU B 902 SITE 2 AC2 14 LEU B 927 MET B 929 GLU B 930 TYR B 931 SITE 3 AC2 14 LEU B 932 PRO B 933 GLY B 935 LEU B 983 SITE 4 AC2 14 GLY B 993 PHE B 995 CRYST1 36.854 182.726 52.766 90.00 110.41 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027134 0.000000 0.010097 0.00000 SCALE2 0.000000 0.005473 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020221 0.00000